93 related articles for article (PubMed ID: 30548305)
1. TIGD1, a gene of unknown function, involves cell-cycle progression and correlates with poor prognosis in human cancer.
Yin L; Yan J; Wang Y; Sun Q
J Cell Biochem; 2019 Jun; 120(6):9758-9767. PubMed ID: 30548305
[TBL] [Abstract][Full Text] [Related]
2.
Zou J; Zhang H; Wu Z; Hu W; Zhang T; Xie H; Huang Y; Zhou H
Cancer Biother Radiopharm; 2024 Apr; 39(3):223-235. PubMed ID: 36508261
[No Abstract] [Full Text] [Related]
3. Elevated expression of the centromere protein-A(CENP-A)-encoding gene as a prognostic and predictive biomarker in human cancers.
Sun X; Clermont PL; Jiao W; Helgason CD; Gout PW; Wang Y; Qu S
Int J Cancer; 2016 Aug; 139(4):899-907. PubMed ID: 27062469
[TBL] [Abstract][Full Text] [Related]
4. Bioinformatics analysis and experimental verification of TIGD1 in non-small cell lung cancer.
Xia L; Yang Z; Xv M; Wang G; Mao Y; Yang Y; Tang J
Front Med (Lausanne); 2024; 11():1374260. PubMed ID: 38651061
[TBL] [Abstract][Full Text] [Related]
5. Expression and prognosis analyses of the Tob/BTG antiproliferative (APRO) protein family in human cancers.
Bai Y; Qiao L; Xie N; Shi Y; Liu N; Wang J
PLoS One; 2017; 12(9):e0184902. PubMed ID: 28922388
[TBL] [Abstract][Full Text] [Related]
6. Reduced expression of IQGAP2 and higher expression of IQGAP3 correlates with poor prognosis in cancers.
Kumar D; Hassan MK; Pattnaik N; Mohapatra N; Dixit M
PLoS One; 2017; 12(10):e0186977. PubMed ID: 29073199
[TBL] [Abstract][Full Text] [Related]
7. The transcription levels and prognostic values of seven proteasome alpha subunits in human cancers.
Li Y; Huang J; Sun J; Xiang S; Yang D; Ying X; Lu M; Li H; Ren G
Oncotarget; 2017 Jan; 8(3):4501-4519. PubMed ID: 27966459
[TBL] [Abstract][Full Text] [Related]
8. Association between the expression of secreted phosphoprotein - related genes and prognosis of human cancer.
Tu Y; Chen C; Fan G
BMC Cancer; 2019 Dec; 19(1):1230. PubMed ID: 31849319
[TBL] [Abstract][Full Text] [Related]
9. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
Front Immunol; 2019; 10():6. PubMed ID: 30761122
[No Abstract] [Full Text] [Related]
10. Systematic analysis of gene expression alterations and clinical outcomes of adenylate cyclase-associated protein in cancer.
Xie S; Shen C; Tan M; Li M; Song X; Wang C
Oncotarget; 2017 Apr; 8(16):27216-27239. PubMed ID: 28423713
[TBL] [Abstract][Full Text] [Related]
11. HGFAC expression decreased in liver cancer and its low expression correlated with DNA hypermethylation and poor prognosis.
Yin L; Mu Y; Lin Y; Xia Q
J Cell Biochem; 2019 Jun; 120(6):9692-9699. PubMed ID: 30635948
[TBL] [Abstract][Full Text] [Related]
12. Systematic analysis of gene expression alterations and clinical outcomes of STAT3 in cancer.
Cui X; Jing X; Yi Q; Long C; Tan B; Li X; Chen X; Huang Y; Xiang Z; Tian J; Zhu J
Oncotarget; 2018 Jan; 9(3):3198-3213. PubMed ID: 29423040
[TBL] [Abstract][Full Text] [Related]
13. Integrative data mining and meta-analysis to investigate the prognostic role of microRNA-200 family in various human malignant neoplasms: A consideration on heterogeneity.
Yuan L; Bing Z; Yan P; Li R; Wang C; Sun X; Yang J; Shi X; Zhang Y; Yang K
Gene; 2019 Oct; 716():144025. PubMed ID: 31394177
[TBL] [Abstract][Full Text] [Related]
14. TP53 mutations as potential prognostic markers for specific cancers: analysis of data from The Cancer Genome Atlas and the International Agency for Research on Cancer TP53 Database.
Li VD; Li KH; Li JT
J Cancer Res Clin Oncol; 2019 Mar; 145(3):625-636. PubMed ID: 30542790
[TBL] [Abstract][Full Text] [Related]
15. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
Gene; 2019 May; 698():9-18. PubMed ID: 30825595
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive genomic and prognostic analysis of the IL‑17 family genes in lung cancer.
Liao T; Fan J; Lv Z; Xu J; Wu F; Yang G; Huang Q; Guo M; Hu G; Zhou M; Duan L; Wang S; Jin Y
Mol Med Rep; 2019 Jun; 19(6):4906-4918. PubMed ID: 31059089
[TBL] [Abstract][Full Text] [Related]
17. TP53 mutations, expression and interaction networks in human cancers.
Wang X; Sun Q
Oncotarget; 2017 Jan; 8(1):624-643. PubMed ID: 27880943
[TBL] [Abstract][Full Text] [Related]
18. Pathological Significance and Prognostic Value of Surfactant Protein D in Cancer.
Mangogna A; Belmonte B; Agostinis C; Ricci G; Gulino A; Ferrara I; Zanconati F; Tripodo C; Romano F; Kishore U; Bulla R
Front Immunol; 2018; 9():1748. PubMed ID: 30127783
[TBL] [Abstract][Full Text] [Related]
19. Dual prognostic role of 2-oxoglutarate-dependent oxygenases in ten cancer types: implications for cell cycle regulation and cell adhesion maintenance.
Chang WH; Forde D; Lai AG
Cancer Commun (Lond); 2019 Apr; 39(1):23. PubMed ID: 31036064
[TBL] [Abstract][Full Text] [Related]
20. The expression profile and prognostic significance of eukaryotic translation elongation factors in different cancers.
Hassan MK; Kumar D; Naik M; Dixit M
PLoS One; 2018; 13(1):e0191377. PubMed ID: 29342219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
